Japan-based Nippon Shinyaku has entered into an option agreement with US-based Elixirgen Therapeutics, Inc. under which ...
Mubadala Bio has announced the signing of a licencing and supply agreement with Biosidus, a leading biotechnology compan...
NeuroSense Therapeutics has reported positive biomarker findings from its Phase 2 RoAD proof-of-concept study of PrimeC ...
China-based ATLATL Innovation Center, a global innovation platform for life science research and development, and Korea'...
Ollin Biosciences has completed an oversubscribed US$330 million Series B financing to advance global Phase III developm...
Innovent Biologics has dosed the first patient in the Chinese pivotal Phase III TriadicMM-1 trial of IBI3003 for relapse...
As biotech innovation accelerates, Asia emerges as an increasingly important hub, driv...
Cincinnati's life sciences ecosystem is gaining momentum through a unique combination of scientific excellence, collabor...
During BIO 2026 in San Diego, BioSpectrum Asia spoke with Kurt Imhof, Senior Vice President, Policy & Public Affairs...
During the BIO International Convention 2026 (June 22–25) in San Diego, BioSpectrum Asia spoke with Arthur Jackson...
NVIDIA announced NVIDIA BioNeMo Agent Toolkit, which provides domain-specific tools and skills for the agentic life scie...
As obesity treatment evolves beyond weight loss toward comprehensive cardiometabolic disease management, pharmaceutical ...
Palmer Holland has partnered with FerrinX to distribute NanoFerrin, a precision-fermented form of lactoferrin for skinca...
The Department of Health – Abu Dhabi and Biocom California have announced a strategic partnership to create a form...
While antimicrobial resistance (AMR) is often overshadowed by high-profile therapeutic areas such as oncology, its growi...
AnHorn Medicines has received U.S. FDA Investigational New Drug clearance and Taiwan Center for Drug Evaluation Index Ca...
China-based CARsgen Therapeutics, a company focused on developing innovative CAR T-cell therapies, has announced that as...
ChemT Biotechnology, an AI-driven biotechnology startup in Singapore building the intelligence layer for biomanufacturin...
The COVID-19 pandemic demonstrated that scientific discovery can move at extraordinary speed, but it also expose...
Despite decades of advances in oncology, many solid tumours remain difficult to treat effectively without exposing patie...
The RNA revolution is entering a new chapter. While mRNA transformed the industry's perception of nucleic acid therapeut...
After several years of volatility, biotechnology financing has returned—but under very different rules. Investors ...
As biotechnology enters an increasingly data-driven era, organisations are rethinking how discovery, clinical developmen...
As biologics and cell and gene therapies continue to advance, manufacturing infrastructure is emerging as a critical det...
As biotechnology enters a new phase of disciplined investment and precision-driven innovation, leaders who can bridge sc...
